← Open Payments lookup

JESSICA VIGOA: Open Payments

NPI 1922471903 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,427 in 91 payments from 18 companies in 2025. Trend: 2023 $1,853 · 2024 $2,485 · 2025 $2,427

Food & beverage: $2,393Education: $34
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP14$497
GlaxoSmithKline, LLC.20$412
Regeneron Healthcare Solutions, Inc.13$352
GENZYME CORPORATION6$215
BioCryst US Sales Co., LLC11$210
Amgen Inc.7$140
Genentech, Inc.1$139
Novartis Pharmaceuticals Corporation4$100
Genentech USA, Inc.3$65
Lilly USA, LLC2$60

Products named: TEZSPIRE, DUPIXENT, NUCALA, ORLADEYO, Xolair, TRELEGY ELLIPTA, EBGLYSS, Andembry.

Industry payments across FL — which companies pay providers there.